A comparison of 5′ RNA-seq methods. We attempted to optimize each of the five methods under comparison ( Fig. 1) to facilitate efficient library construction and the sequencing of indexed libraries on an Illumina platform (Methods). We tested each method by using RNA from the K-562 human cell line to construct and sequence 18 libraries (Supplementary Table 1 ). The methods vary in their input RNA requirements, with STRT, which was developed as an ultralow-input method, requiring the least RNA, and oligo-capping requiring the most (Methods). We sought to use the lowest recommended amount for each method, recognizing that RNA quantity can be limiting in practice. To assess whether the lower input for STRT affects its performance, we constructed and sequenced an 
P
recise promoter annotation is central to many issues in biology, including condition-and tissue-specific gene regulation, differential 5′ untranslated region usage, and the effect of genetic variation in noncoding regions on gene expression. In particular, the correct identification of TSSs can be critical for relating noncoding variants to their mechanism of action 1, 2 . For example, a single-nucleotide polymorphism can cause thalassemia by creating a new TSS that interferes with normal activation of downstream α -like globin genes 3 . Identifying multiple TSSs for a gene and understanding their usage in relevant tissues can also help in the design of follow-up experiments. Furthermore, differential TSS usage is often important for gene function and in human disease 4 ; for the TP73 locus, transcription from alternative promoters leads to the expression of protein variants with either tumor suppressor or oncogenic activity 5 , and the disruption of the alpha or beta promoters of NRXN1 may lead to differences in the constellation of neurodevelopmental symptoms 6 . Although RNA-seq is a powerful approach for quantifying gene expression, discovering previously unknown transcripts, and determining splice isoforms 7 , it is often difficult to reliably identify more than one TSS per gene. Empirical determination of the correct TSSs in a given sample is particularly important in complex transcriptomes, such as human, where 54% of genes are currently annotated as having multiple TSSs 8 . Several methods have been designed to identify the 5′ end of transcripts, including CAGE 9 , RNA annotation and mapping of promoters for the analysis of gene expression (RAMPAGE) 10, 11 , single-cell tagged reverse transcription (STRT) 12 , nano-cap analysis of gene expression (NanoCAGE) 13, 14 , oligocapping (also known as TSS-seq) 15, 16 , and global nuclear run-on cap (GRO-cap) 17 (also known as 5′ GRO-seq 18 ) ( Fig. 1 ), but their relative merits have not been systematically compared 19 . Even a widely accepted method such as CAGE produces many reads that align to 3′ rather than 5′ transcript ends 20 , which suggests that further investigation could be beneficial.
We compared six 5′ RNA-seq methods using a comprehensive set of metrics. Starting from total RNA from one human cell line, we constructed a set of libraries for five of the methods, as well as a control library with standard RNA-seq, and deeply sequenced them. We identified the CAGE method as the best performer for mRNA and found that most of its unannotated TSS peaks also have corroborative evidence to support their being bona fide TSSs. For enhancer RNAs (eRNAs), we found that GRO-cap identified many more transcripts than the other methods. We then used CAGE to generate TSS data for eight brain-related samples, thus identifying many examples of differential promoter usage, and providing evidence for a previously unknown, genome-wide trend of differential TSS usage, in which downstream TSSs are preferentially used in adult brain and upstream TSSs are used in fetal brain and in vitro differentiated neurons. Our evaluation strategy, results, and brain TSS catalog can serve as resources for the community.
. We constructed one control library using standard RNA-seq with ribosomal RNA (rRNA) depletion by the RNase H method 19, 21 to understand the value of using one of these more specialized RNAseq methods.
We first assessed the performance of each method using standard RNA-seq metrics (Supplementary Table 1 ). CAGE and NanoCAGE-XL produced fewer reads per library as a result of limited quantities of library DNA for CAGE and poor sequencing yield for NanoCAGE-XL. All methods showed acceptable levels of reads aligning to rRNA (< 20% of reads) and excellent strand specificity (> 99% correct strand reads) with the exception of GRO-cap (90% correct strand reads). GRO-cap also had a much higher fraction of reads aligning to introns (20%) and intergenic regions (47%) than the other 5′ -end RNA-seq methods.
For an initial assessment of specificity for 5′ ends, we examined coverage of reads from 5′ to 3′ (Fig. 2a,b) . When considering only reads that aligned to exonic regions, we observed that GRO-cap performed best, followed by CAGE and RAMPAGE; NanoCAGE-XL performed worst (Fig. 2a) . Analyzing reads aligning to the entire gene, including introns, we observed that RAMPAGE and CAGE performed best, followed by GRO-cap (Fig. 2b) , probably reflecting the high fraction of GRO-cap reads that align to introns (Supplementary Table 1 ). This global analysis is congruent with our observations for representative highly expressed genes ( Supplementary Fig. 1 ). Overall, even the method with the best performance, CAGE, had a sizeable fraction of reads (24% for the average gene) that mapped to regions far from transcript 5′ ends (farther than 10% of transcript length) by this measure (Fig. 2a) .
Assessment of 5′-end specificity with spike-ins. We next explored why many reads did not align at the annotated 5′ end of transcripts (Fig. 2a) . Such non-5′ -end reads could reflect technical limitations, incomplete annotation, or biological explanations such as RNA recapping 22 . To focus on technical performance, we developed a spike-in RNA assay that uses External RNA Controls Consortium (ERCC) transcripts 23 (Methods). The methods showed similar relative performance on the basis of 5′ -end coverage of these artificial transcripts (Fig. 2c and  Supplementary Table 2 ) as with cellular RNA (Fig. 2a) , with CAGE and RAMPAGE performing best. STRT performance did not improve with increased input amounts (Supplementary Table 2 ). The 5′ -end specificity differed among the spike-in transcripts, indicating that there is some variability in method performance for different transcripts.
We also assessed how accurately these methods quantitated the relative fraction of each ERCC spike-in transcript. This is important Salient details for five protocols tested in this paper. Additional properties of these protocols can be found in Supplementary Table 8 . 
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for quantifying differences in TSS usage across samples. For each transcript, we compared the relative input amount to the fraction of reads aligned (Supplementary Table 3 ). We assessed the uniformity of read coverage using the mean quantitation error (Supplementary Table 4 ). The CAGE libraries had the lowest error (1.1%) and performed better than RAMPAGE (2.0%).
TSS peak-calling to help assess 5′ specificity. To better compare the 5′ specificity of methods for cellular transcripts, we used computational peak-calling to identify TSS locations. We reasoned that this would distinguish noisy background reads spread across the length of a gene from peaks of reads aligning to specific locations in that gene. Furthermore, many studies seek to identify TSS peaks and associate them with other genomic and biological information. To enable equivalent comparisons across methods, we randomly sampled 20 million aligned reads for each method, with two exceptions. First, NanoCAGE-XL did not yield sufficient reads (Supplementary Table 1) , so we used all of its aligned reads. Second, we did not have enough reads from any single CAGE library; we therefore pooled replicate libraries for subsequent analysis. We called peaks from aligned reads using Paraclu 24 , with parameters optimized for best sensitivity and precision for each library (Methods). We also incorporated two additional filtering steps to ensure that our peak-calling results accurately represented lab method performance (Supplementary Note 1 and Supplementary Figs. 2-4) . CAGE performs best in TSS peak-based comparison. We evaluated each of the six methods for their ability to identify TSSs relative to known annotation. We used the UCSC transcriptome annotation 8 , which does not rely on data gathered with 5′ -end RNA-seq methods, and thus should not be biased toward any of the methods a priori. For precision, CAGE, STRT, and NanoCAGE-XL performed best (Fig. 3a) , whereas GRO-cap was the best method in terms of sensitivity, followed by CAGE and RAMPAGE (Fig. 3a) . With both of these factors considered equally, CAGE performed best, followed by RAMPAGE, GRO-cap, STRT, NanoCAGE-XL, and oligocapping (Fig. 3a,b) . STRT performance did not improve with increased input amounts ( Supplementary Fig. 5 ). We obtained the same rankings when we used the Gencode annotation 25 ( Supplementary Fig. 6 ). In addition, we analyzed published datasets in which two of these methods were tested on the same cell line or tissue in different laboratories. In three cases, we were able to compare CAGE and another method, and found that CAGE (a) and number (b) of peaks with support from each corroborative data source (color legend) is indicated for peaks initially defined as 'true positive', 'false positive', and 'intergenic' on the basis of the UCSC annotation. a, Peaks were assigned to only one category of support on the basis of their corroboration by Gencode annotation, consensus of four best 5′ -end methods, DNase-seq, or H3K4me3 ChIP-seq data in this order (for example, a peak corroborated by Gencode is not listed in the other categories even if it has additional support). b, Peaks were assigned to as many corroborative categories as evidence supported. c, TSS prediction with CAGE, DNase-seq, and H3K4me3 ChIP-seq data. Because peaks for different data types differ by length and genomic position, multiple peaks of one type can overlap with one peak of another type. For all overlaps involving CAGE peaks, the numbers of peaks in overlapping categories correspond to CAGE peaks. In the overlap of H3K4me3 ChIP-seq and DNase-seq peaks, but not CAGE peaks, we report the number of DNase-seq peaks. For each subset of CAGE peaks, we also show the percentage of true positives (TPs) out of all of the CAGE peaks in that category. Areas are not to scale. Supplementary Fig. 7 ). We also compared the performance of standard RNA-seq (Methods), which generated more peaks, leading to more true and false positives. The standard RNA-seq receiver operating characteristic (ROC) curve suggested a similar ratio of false to true positives as observed with NanoCAGE-XL, which identified the fewest peaks, but revealed that the performance was worse than that of all of the other 5′ -end methods except oligo-capping (Fig. 3b) .
For each method, we also assessed TSSs at single-base resolution (Supplementary Note 2 and Supplementary Fig. 8 ), as well as reproducibility and gene expression quantification accuracy Evidence supporting unannotated TSS peaks. Given that CAGE performed best, we explored its performance further using evidence from other sources. DNase-seq and H3K4me3 ChIP-seq data can be used to understand which false positives (based on prior annotation) may actually be true positives. DNase Indeed, when epigenetic data, Gencode annotations, and the consensus peaks identified by the other 5′ -end RNA-seq methods are considered, the vast majority of CAGE peaks have additional support (Fig. 4) . First, ~55% of false positive and ~42% of intergenic peaks for CAGE have support from Gencode annotation and/or the consensus peaks identified by the other 5′ -end RNA-seq methods (Fig. 4a) . We omitted NanoCAGE-XL from this consensus because it detected so few peaks (Fig. 3a,b ). Next, with corroborative evidence from DNase-seq or H3K4me3 ChIP-seq 28 , the great majority of the remaining unannotated peaks have some evidence that they may represent actual TSSs (Fig. 4a,b) . We also analyzed corroborative evidence for other methods (Supplementary Note 4 and Supplementary Fig. 11 )
Although TSSs are associated with promoters, they can also be found at the start of eRNAs and would be classified as 'intergenic' in the annotation that we have used previously 32, 33 . We explored the locations of intergenic Paraclu-called peaks ( Supplementary Fig. 11 ) relative to enhancer regions in the genome. Using three different approaches based on histone modifications and open chromatin to identify enhancer regions (Methods), we observed that GRO-cap had ~5,000 peaks in such regions, whereas the other methods had far fewer peaks (Supplementary Table 5 ). The percentage of intergenic peaks that were found in enhancer regions revealed the same trend as that of peaks in annotated genes (Fig. 3) , with most methods performing well, except for oligo-capping (Supplementary Table 5 ). Because eRNAs are expressed at lower levels than mRNAs and are expressed as divergent, nonoverlapping transcript pairs, we took a second approach based on a previous study 33 (Methods) to identify peaks in such regions. We obtained similar results in that GRO-cap revealed the most TSSs in enhancer regions (Supplementary Table 6 ).
When considering whether CAGE data are sufficient to identify TSSs in a given sample, it is worth knowing whether collecting corroborative data via a method such as DNase-seq or H3K4me3 ChIP-seq can improve the quantity or confidence of the identified TSSs (Fig. 4c) . In our data, more CAGE peaks would be filtered out with a requirement for DNase-seq evidence than for H3K4me3 ChIP-seq evidence (Fig. 4c ). For standard RNA-seq without CAGE data, the corroborative evidence is even more important for identifying 'true positive' 5′ ends, based on annotation, with DNaseseq evidence again having a bigger effect than H3K4me3 ChIP-seq ( Supplementary Fig. 12 ).
Differential TSS usage in brain-related samples.
Having identified the superior performance of CAGE, we applied it to a set of eight brain-related samples to explore differential TSS usage. We selected cell-type populations derived from postmortem brain (neurons, astrocytes, endothelial cells, and smooth muscle), postmortem fetal and adult frontal lobe samples, 26-d-old in vitro neurons produced with an NGN1 (NEUROG1) and NGN2 (NEUROG2) overexpression differentiation protocol 34 , and 60-d-old in vitro brain organoids 35 . For each sample, we sequenced CAGE libraries, sampled 13 million aligned reads, called peaks using ParaClu, and applied CapFilter (Methods). We intentionally focused on differences in TSS usage rather than on expression levels (Methods) to explore the specific information added by CAGE compared with that added by standard RNA-seq. In addition, we wanted to identify the most significant differences in TSS usage, which can be difficult to discern for genes with low expression. To identify TSS peaks that are differentially used between pairs of samples, we compared for each gene the fraction of reads in a TSS peak between samples. This method identified 2,312 TSS peaks in 1,015 genes that were significantly different (FDR < 0.05, Fisher's exact test) between at least one pair of these eight samples (Supplementary Table 7 ). Unsupervised hierarchical clustering of the differentially used TSSs showed relationships among these samples, such as the in vitro models of neuron development being most closely related to the fetal frontal lobe sample (Fig. 5a ). For comparison purposes, we also performed unsupervised hierarchical clustering using gene expression levels rather than TSS usage (Supplementary Fig. 13 ) and observed that the resulting clustering of samples was similar to that shown in Fig. 5a .
Our analysis highlighted three brain-disease-associated genes with differential TSS expression between fetal and adult samples (Fig. 5b) . For ANK3, which has been associated with bipolar disorder and schizophrenia 36 , the T2 (exon 1e) 37 TSS was more frequently used than the T3 (exon 1b) 37 TSS in all of the samples except the adult frontal lobe, consistent with published findings 37 . For GPR56 (ADGRG1), the T4 (e1m 38 ) TSS, which has been reported to be the TSS with the highest expression in fetal human brain and is required for normal embryonic cortical development 38 , was used more frequently in the fetal frontal lobe, in . The x axis is the average difference of the number of peaks active (defined as overlapping at least one read) in each data set for all genes (Methods). Error bars, 95% confidence interval. For b and c, the P values were calculated via Wilcoxon signed-rank test (Methods); *P < 0.05 (Bonferronicorrected). The P values can be found in the source data for this figure, published online. For all panels, n = 1 library per sample, except iPS FANTOM5, which combines data for two replicate libraries.
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vitro neurons, and brain organoids, but not in the adult frontal lobe, in which T3 was used more often. For RTN4 (also known as NOGO), we observed that the T3 (P2, NOGO-C 39 ) TSS, which is overexpressed in schizophrenia, was used more frequently in the adult frontal lobe, similar to previous findings 39 , but not in the other samples. For all three genes, TSS usage in adult frontal lobe was more similar to that in brain organoids than that in in vitro neurons (Fig. 5b) , as might be expected given the more advanced development of the organoids 35 . More globally, in vitro neurons, brain organoids, and fetal frontal lobe used an upstream (more 5′ ) TSS rather than a downstream (more 3′ ) TSS significantly more often (Bonferroni adjusted P < 0.05) than did adult frontal lobe (Fig. 6a,b) . For this comparison, we computed a scaled average peak position for all genes and datasets, which were compared between samples via a paired Wilcoxon signed-rank test (Methods). TSS usage was most significantly different between in vitro neurons and adult frontal lobe (Bonferroni adjusted P = 0.0002), with significant differences also observed between fetal and adult frontal lobe (Bonferroni adjusted P = 0.0013) and between brain organoids and adult frontal lobe (Bonferroni adjusted P = 0.023; Fig. 6b ). We also observed this trend when we used FANTOM5 CAGE data from similar samples 27 (Fig. 6b) . Moreover, the number of TSSs per gene was significantly higher (Bonferroni adjusted P = 2.1 × 10 −32 ) in the adult frontal lobe than in the in vitro neuron or organoid samples from this study, as well as in the adult FANTOM5 brain samples compared with the fetal FANTOM5 brain samples (Fig. 6c ).
discussion
Our comparison of six 5′ RNA-seq methods indicates that CAGE performed best overall (Figs. 2 and 3) , although other methods might be used when less RNA is available. GRO-cap should be considered for the identification of eRNA TSSs (Supplementary  Tables 5 and 6 ), but it performed worse for mRNA TSSs as a result of a higher rate of false positives (Fig. 3) , particularly in genomic regions annotated as introns (Supplementary Table 1 ). Although many peaks identified by GRO-cap could be real on the basis of corroborative evidence ( Supplementary Fig. 11 ), this is difficult to judge. Furthermore, GRO-cap is limited to fresh samples and relies on the TAP enzyme, which is no longer commercially available. The methods also vary in the associated time and cost of materials and kits (Supplementary Table 8 ). The per-sample cost is lowest for STRT and highest for oligo-capping. The amount of time and number of steps per library for each method is lowest for STRT and NanoCAGE-XL and highest for CAGE.
We aimed to test a fully representative set of the existing methods for 5′ RNA-seq, but we excluded some from our comparisons (Supplementary Note 5).
A key question was which methods were best for annotating TSSs in a sample without previous annotation. Beyond finding that CAGE performed best, we found that DNase-seq and H3K4me3 were insufficient without CAGE to reliably identify TSSs (Fig. 4) . Moreover, DNase-seq, but not H3K4me3, does provide additional specificity beyond CAGE. Of course, it is not possible to know with full certainty whether any given TSS identified by these methods is correct. For standard RNA-seq, DNase-seq and, to a lesser extent, H3K4me3 are more valuable for identifying true TSSs based on the annotation, although there are still more false positives with standard RNA-seq than with CAGE even with the corroborative data ( Supplementary Fig. 12 ). ATAC-seq 40 could be substituted for DNase-seq, as the former is simpler, with lower input requirements.
Finally, we used TSS usage to assess disease models. Human pluripotent stem cells are an excellent tool for the modeling of human disorders in the lab 41, 42 and are particularly relevant for brain-related disorders for which other models are limited 43, 44 . We compared TSS usage in in vitro neurons and brain organoids derived from human pluripotent stem cells with that in postmortem brain samples (Figs. 5 and 6) to understand how faithfully these models represent actual brain tissue at a transcriptional level. Our results provide a resource for future studies and add to the existing literature in this field 27, 45 . Brain organoids were more similar than in vitro neurons to adult postmortem brain samples, as determined by our TSS usage measures (Figs. 5a and 6b), which suggests that the former might be a better model on the basis of these criteria. It is likely that some of the observed differences can be explained by postmortem brain having cell types that are not found in these in vitro models, and potential changes in RNA abundance resulting from deathassociated cellular responses to hypoxia and other factors 46 .
With the brain-related samples, relative TSS usage significantly varied with respect to upstream or downstream position within each gene (Fig. 6) . Because the size of this effect seemed to reflect overall sample relatedness (Fig. 5a ) and we identified this pattern in an unrelated CAGE data set (Fig. 6b) , we believe that there may be a biological explanation underpinning this result. To the best of our knowledge, this phenomenon has not been observed previously, but studies of 3′ transcript ends have shown that upstream polyadenylation sites are preferentially used in proliferating cells 47 , whereas the opposite has been reported in mammalian brain 48 . In addition, a recent study detected unannotated TSSs upstream of annotated, silenced promoters that may be relevant to aberrant gene expression in cancer resulting from hypomethylation of these upstream TSSs 49 .
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41592-018-0014-2. We prepared four brain organoids from a single batch at day 60 of differentiation from H9 embryonic stem cells as previously described 50 . We isolated total RNA using 1 ml of Trizol (Thermo Fisher Scientific) according to the manufacturer's instructions and isopropanol precipitated with 1 μ l of GlycoBlue Coprecipitant (Thermo Fisher Scientific). We removed the GlycoBlue, which inhibited the CAGE process, by mixing the samples with 30 μ mol of LiCl (Sigma) in a total of 12 μ l, incubating at -20 °C for 20 min, and then centrifuging at 4 °C at maximum speed (17,000g). We removed the supernatant, rinsed the pellet with 70% ethanol, and resuspended the pellet in 8.22 μ l of H 2 O. We repeated this process one more time until there was no visible GlycoBlue. RIN scores for these eight samples were 6.8 to 9.7, as measured by BioAnalyzer.
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All biospecimens were collected with informed consent. The generation of human embryonic stem cells used in this study was approved by the institutional review boards (IRBs) of the providing institutions. Use of all de-identified biospecimens for sequencing at the Broad Institute was further approved and reviewed by the Broad's Office of Research Subject Protection (ORSP), which determined that the research did not involve human subjects according to US federal regulations (45CFR46.102 f). This study complied with all relevant ethical regulations.
RNA spike-in controls.
We obtained 32 individual ERCC spike-in controls 23 (gift from J. McDaniel and M. Salit, NIST). We added an m7G cap structure to the 5′ end of RNA molecules using the Vaccinia Capping System (New England BioLabs), following the manufacturer's protocol. We made a pooled capped ERCC spike-in mix with an average concentration of 36 pg/μ l for each transcript. In addition, we prepared a second pooled, capped ERCC spike-in mix with only eight of the transcripts with an average concentration of 138 pg/μ l for each transcript. We also made a third pooled original (uncapped) ERCC spike-in mix for all 32 transcripts with average concentration of 60 pg/μ l for each transcript.
CAGE libraries.
For K-562 samples, we prepared libraries according to a published protocol 9 using 10 μ g of total RNA for three replicates (Main-1, 4, and 6) from the same batch of RNA. In a second experiment, we prepared a library with a single replicate (Repeat) from 5 μ g of a different batch of K-562 RNA. For the brainrelated samples, we prepared CAGE libraries from eight total RNAs from sources described above, using between 5 and 10 μ g each based on availability.
For the Main-1, Main-4, and brain-related samples, we added pooled capped ERCC spike-in RNA to each sample in a ratio of 0.128 μ l per μ g of sample input. For the Main-6 sample, we added 1.28 μ l of pooled, uncapped ERCC spike-in RNA. For the other replicate (Repeat), we added 1.0 μ l of pooled capped ERCC spike-in mix containing only eight transcripts.
RAMPAGE libraries.
We prepared the libraries according to a published protocol 11 using 5 μ g of K-562 total RNA plus 0.64 μ l of pooled capped ERCC spike-in RNA with the following modifications. (1) We used a universal template switching oligo 5′ -TAGTCGAACTGAAGGTCTCCAGCArGrGrG-3′ instead of the barcoded ones. (2) We used a random 15-mer oligo with a modified tag sequence for RT to allow an index read later on in sequencing 5′ -TAGTCGAACG AAGGTCTCCCGTGTGCTCTTCCGATCT(N)15. (3) In the final PCR, we used an 8-base barcoded reverse primer to add an index for each individual library, 5′ -CAAGCAGAAGACGGCATACGAGATXXXXXXXXGTGACTGGAGTTCAG ACGTGTGCTCTTCCGATCT-3′. (4) We used a different custom sequencing primer (Supplementary Table 9 ). We also made a replicate with a different batch of K-562 RNA with 1.0 μ l of pooled capped ERCC spike-in mix containing only eight transcripts.
STRT libraries.
We synthesized cDNA from 10 ng of K-562 total RNA plus 0.64 μ l of 1/500× dilution of pooled original, uncapped ERCC spike-in RNA, following a published protocol 12 , combined with reverse-transcription PCR conditions based on SMART-Seq2 51 and the following modifications. (1) We used a 5′ biotin blocked dT oligo that contains a SalI restriction site (shown as underlined), 5′ -/5Biosg/CTACACGACGCTCTTCCGATCTGTCGACT(30)VN-3′ . (2) We used a 5′ template switching oligo (TSO) containing an Illumina adaptor sequence, 5′ -CUACACGACGCUCUUCCGAUCUNNNNNGGG, noting all bases are RNA. We made this switch because this oligo is compatible with HiSeq2500, MiSeq, and NextSeq sequencers (lllumina), whereas the original one 12 requires a custom sequencing primer with an annealing temperature that is only suitable for the HiSeq2000. (3) We used a PCR primer with sequence compatible to dT oligo and 5′ TSO, 5′ -CTACACGACGCTCTTCCGATCT-3′ , for cDNA amplification. We then eliminated the poly(A)/(T) end of the double-stranded cDNA by mixing with 1× CutSmart buffer, 10 units of SalI (New England BioLabs) and heating at 37 °C for 60 min. We purified this product by using 0.7× volume AMPureXP SPRI beads (Beckman Coulter Genomics) according to the vendor's protocol. We made the sequencing library with a modified NexteraXT (Illumina) protocol 52 with the following additional modifications. (1) We used 0.125 ng of cDNA in ½ volume of a standard NexteraXT reaction. (2) We used the modified Nextera Index 1 primer, 5′ -CAAGCAGAAGACGGCATACGAGATXXXXXXXXGTCTCGTGGGCTC GGAGA*T*G-3′ with phosphorothioate bonds (denoted by *) and inverted end bases for protection; the 8 'X' bases indicate in-line index sequences that enable pooling samples. In the same experiment, we also prepared a library with the same quantities of capped ERCC spike-in RNA and K-562 RNA. We also made a replicate with a different batch of K-562 RNA.
In addition, we constructed STRT libraries using a similar protocol as above with 10 ng, 100 ng, 1 μ g, 5 μ g, and 10 μ g K-562 total RNA from the same batch as above together with the same proportion of uncapped ERCC spike-in RNA. We made the following modifications to accommodate the higher inputs. (1) For the 5-μ g and 10-μ g inputs, we used 4× as much volume for the RT reaction. (2) We used 10 μ l each of the 10× diluted first strand cDNA from the 1-μ g RNA input, 12.5× diluted ones from the 5-and 10-μ g RNA inputs, into the 50 μ l of cDNA PCR amplification reaction. (3) We used a 50-μ l reaction volume that contained 40 units of SalI to remove the poly(A)/(T) end of the double-stranded cDNAs generated in all the higher-input RNA libraries.
Oligo-capping libraries. We prepared the library by following published protocols 16, 53 , using 40 μ g of K-562 total RNA plus 5.12 μ l of pooled capped ERCC spike-in RNA with the following modifications. (1) We used 0.5 μ l of glycogen (Roche) as the carrier instead of ethachinmate in the ethanol precipitation step. (2) We used KAPA HotStart Ready Mix (KAPA Biosystems) instead of GeneAmp PCR kits (PerkinElmer) for PCR amplification. (3) We selected 250-600 bp instead of 150-250-bp PCR products for sequencing.
NanoCAGE-XL libraries.
We prepared a library using 7.5 μ g of K-562 total RNA plus 0.96 μ l of pooled capped ERCC spike-in RNA by following a published protocol 14 with the following modifications. (1) We used a TSO containing a 6-base barcode (marked as XXXXXX) followed by a 6-base spacer, 5′ -TAGTCGAACTGAAGGTCTCCAGCAXXXXXXGCTATArGrGrG. (2) We used a modified custom sequencing primer (Supplementary Table 9 ).
Standard RNA-seq library. We prepared a library using 1 μ g of K-562 total RNA plus 2 μ l of 1:100 diluted ERCC spike-in mix 1 (Ambion) using the TruSeq RNASeq kit (Illumina) with the following modifications. (1) We depleted rRNA by using the RNase H method 19 instead of using oligo(dT) selection. (2) We eluted the rRNA depleted RNA from the SPRI beads using EPF buffer from the TruSeq kit and heated it at 70 °C for 10 min. (3) We used a different set of barcoding indices rather than those in the TruSeq kit for the ligation and final PCR steps.
Sequencing. Libraries were sequenced on HiSeq2500, MiSeq, or NextSeq machines (Illumina), as detailed in Supplementary Table 9 . We used paired-end sequencing for some 5′ end libraries to aid our understanding of method performance, but this is not generally required, with the possible exception of RAMPAGE. The NanoCAGE-XL library was sequenced with a second, unrelated library and spiking in 30% PhiX library and loading at a reduced concentration (7 pM) to overcome monotemplate issues with libraries prepared with this method.
Additional 5′ RNA-seq datasets. For datasets previously generated by other groups, we downloaded the relevant FASTQ files (Supplementary Table 10 ) and used them in our method comparisons. For the STRT data 29 , we picked 100 random mouse hippocampus cells from the single-cell dataset and combined them together into one FASTQ file before processing.
Read processing and alignment. For 5′ -end RNA-seq, we processed reads by trimming an appropriate number of bases depending on the lab method used (Supplementary Table 1 ). We aligned reads to either the human genome (Gencode v19) or mouse genome (mm10) with STAR 54 (version 2.4.2a) using two-pass mode, and the softclip option to trim reads and otherwise default parameters. We used only read 1, which was derived from the 5′ end of the transcript, for these analyses, except when we tested the use of read 2 with the RAMPAGE peak-calling pipeline (see below). We generated basic alignment and performance metrics, using CollectAlignmentSummaryMetrics and CollectRnaSeqMetrics in Picard Tools (https://github.com/broadinstitute/picard). We analyzed the reads for both these metrics and peak-calling analyses, but used BAM files generated by STAR with the AnAlysis NATuRE METhodS hardclip option for the former because Picard did not recognize bases as trimmed with the softclip option.
For 5′ -versus 3′ -end coverage, we sampled 20 million reads from each BAM file, except for NanoCAGE-XL, for which we used all reads. We performed two types of analyses, one using the entire gene including intronic regions and the other using only the exonic regions. In both cases, we used only the position of the most 5′ end of the read (read start). For the analysis of the entire gene, we used only genes greater than 500 bp in length and with counts of transcripts per million (TPM) > 1 as estimated with RSEM. We divided each gene into 100 equal-sized bins and totaled the percentage of read starts on the same strand as the gene in each bin on a per-gene basis using bedtools 55 intersect and post-processing in R. We averaged these percentages over all genes, and plotted the results with ggplot 56 . For analysis using only the exonic regions, we used a similar approach, except for genes with more than one transcript, we selected the one with the highest TPM for each gene and limited our analysis to transcripts greater than 500 bp in length and with TPM > 1.
For ERCC spike-in analysis, we used the same trimmed reads, except as noted in Supplementary Table 1 . We aligned to a version of all 92 of the ERCC spike-in RNA sequences that includes all sequences at the 5′ ends (Supplementary Table 11) using BWA 57 and a custom Picard module to parse the aligned BAM file to calculate the coverage at each base of the ERCC spike-in reference sequences.
For standard RNA-seq data, we aligned untrimmed reads with TopHat 58 (version v1.4.1) using default parameters except mate-inner-dist set to 300 and mate-std-diff set to 500, followed by Cufflinks 59 (v2.2.1) using the default settings.
Peak calling. To identify TSSs, we used the Paraclu 24 peak caller, applied to randomly sampled reads as follows. To compare between methods, we randomly sampled 20 million reads from aligned K-562-derived BAM files using a custom shell script, with the exception of NanoCAGE-XL, for which we used all 6,407,741 reads. For other parts of the analysis (reproducibility, MCF-7, mouse hippocampus, human brain-related data, FANTOM5 data) we sampled to different numbers of reads, as detailed below. We sampled only reads from each BAM file that passed platform/vendor quality checks and were flagged as being a primary alignment. For 5′ end methods, 20 million reads are from read 1 only, but for standard RNA-seq, they are from both reads 1 and 2.
Post-processing of ParaClu peaks. We annotated peaks called by ParaClu with several scores to indicate the confidence for increased read density in that region, which were used to remove low-confidence peaks. The ParaClu caller adopts a hierarchical approach to peak calling and calls peaks within peaks 24 . For the purpose of assessing TSS discovery accuracy, we were less concerned with internal peak structure, and therefore merged all overlapping peak regions using the bedtools 55 'merge' function. We set the scores for the aggregate peak to the maximum ParaClu score over the set of peaks to be merged. All peak regions wider than 300 bp or narrower than 3 bp were removed.
To indicate the confidence level for a given peak, ParaClu provides three metrics: D, the 'density rise' , a measure of the fold change between maximum and minimum read density, and an indicator of signal strength; P, the minimum number of positions within the peak covered by reads; and S, the total number of reads mapping to the region within the peak. We could then remove lowconfidence peaks by setting threshold values D min , P min and S min for these three values, respectively, and removing peaks that do not pass all three cutoffs. To identify optimal values for these parameters, we tested all combinations of (integer) values for D min in [0,10], P min in [0, 20] , and S min in [0,180], and assessed peak-calling performance using the F 1 score (see below). To ensure that each 5′ RNA-seq method was analyzed optimally, we repeated this procedure to identify the best parameters for each method, and at the different read depths required for all the comparisons in this study: 20 million for 5′ end RNA-seq lab method comparisons, 7 million for CAGE reproducibility, 5 million for RAMPAGE and STRT reproducibility, and 13 million for brain-related samples, MCF-7, and mouse hippocampus samples. The final filtering parameters used for each data set are shown in Supplementary Table 12 .
We assessed the reproducibility of TSS discovery by using bedtools 55 'intersect' to compute the pairwise overlap between ParaClu peaks called using BAM files generated from four CAGE replicates. We also compared overlaps for pairs of replicates for RAMPAGE and STRT.
Peak-calling from standard RNA-seq data. To identify TSS using full-length RNA-seq reads, we merged aligned reads from two replicates using SAMtools 60 and sampled 20 million reads as described above. With expressed transcripts identified using Cufflinks 59 , we annotated the region within 100 bp of the 5′ end of each identified transcript as a TSS peak.
Tag cluster identification.
To identify TSSs in enhancer regions and understand narrow versus broad peaks, we used an alternative peak-calling method 27 that aims to find tag clusters (TCs). For each read, we defined the starting location of that read as the start of a TSS and then merged all such TSS starts within 20 bp on the same strand to get TCs. We discarded TCs with less than three reads supporting them or longer than 300 bp. We used CapFilter (see "Additional filtering steps" below)
for methods that add an extra G (CAGE, RAMPAGE, NanoCAGE-XL, and STRT). We defined broad peaks as TC > 10 bp in width, and narrow peaks as those ≤ 10 bp.
Peak-calling for enhancers. To identify putative eRNAs in K-562 datasets, we adapted a previously published approach 33 . In particular, we took all intergenic TCs and discarded TCs that overlapped another TC on the opposite strand. We paired reverse-and forward-stranded TCs, where the reverse-stranded TC occurred within < 400 bp of the forward-stranded TC, and merged overlapping pairs together, avoiding overlap between the reverse-and forward-stranded TC in each pair. We then filtered out all merged pairs where either the reverse or forward TC had much higher coverage than the other. More specifically, we only kept merged pairs with
Number reads reverse TC Number reads forward TC Number reads reverse TC Number reads forward TC 0 8
We used the middle point of each of these merged pairs as the center of the putative enhancer, and extended by 200 bp on either side to generate the putative enhancer. We compared these putative enhancers to public H3K27ac ChIP-seq (peaks downloaded from http://hgdownload.cse. ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/ wgEncodeBroadHistoneK562H3k27acStdPk.broadPeak.gz), DNase-seq (see "Corroborative data"), and enhancer region datasets (ENCFF687ZGE) from ENCODE 28 and the DENdb database 61 (http://www.cbrc.kaust.edu.sa/dendb/) using the bedtools 55 'intersect' function with default parameters. Similarly, we compared the intergenic peaks identified with ParaClu to each of the above datasets using the same approach to test whether the peaks overlapped with eRNA.
Identification of TSS initiator sequences.
For identification of the dinucleotide sequences at the start of TSSs (-1 and + 1, where + 1 is the position of the first transcribed base in a transcript and -1 is the position directly before it in the genome), we used a modification of previously published approaches 62, 63 . In particular, we took all TCs within 100 bp of an annotated gene and with at least 10 reads mapping to them, and located the position in each TC with the largest number of reads starting there. We used this location as the putative start site (the + 1 location) for the TC. Note that for methods that add an extra G (CAGE, RAMPAGE, NanoCAGE-XL and STRT), we shifted the putative start site over by one base pair in the 3′ direction. We used bedtools 55 to extract the + 1 and -1 base for each putative TSS from the human genome and created logos using the ggseqlogo package in R 64 .
Additional filtering steps. We evaluated three specialized filtering programs: CapFilter 14 , strand invasion 65 , and the RAMPAGE 10 second read filter (downloaded from http://megraw.cgrb.oregonstate.edu/software/CapFilter, https://academic.oup. com/nar/article/41/3/e44/2902349/Suppression-of-artifacts-and-barcode-bias-inhigh#supplementary-data, https://github.com/philbatut/rampage). For CapFilter and strand invasion, we slightly modified the code to allow applications beyond NanoCAGE-XL, the lab method for which they were originally developed. We applied CapFilter to CAGE, RAMPAGE, NanoCAGE-XL, and STRT. In each case, we began by calling peaks as above and then applied CapFilter to the resulting peaks. This led to a smaller set of final peaks. We tested CapFilter with various settings of the thresholding parameter (which corresponds to the percentage of Gs in the first position), and found that a threshold of 20% seemed to be optimal for all experimental methods (Supplementary Fig. 2 ).
We applied the strand invasion filter 65 to the NanoCAGE-XL and STRT data. This filter removes potentially artifactual reads that are the result of strand invasion, where the PCR primer primes at sequences in the cDNA similar to the template-switching oligonucleotide (TSO) rather than in the TSO. By checking for matches between the TSO and the sequence upstream of read 1, such events can be identified and filtered out. Using all the NanoCAGE-XL aligned reads and 20 million sampled STRT aligned reads from the BAM files, we applied the strand invasion filter, varying the maximum allowed edit distance between the TSO and the upstream sequence, before calling peaks with ParaClu. We tested varying this parameter between 0 and 7, both with and without CapFilter. We found that this filter did not improve on CapFilter when used in combination with CapFilter ( Supplementary Fig. 3a ) and did not include strand invasion in our main analysis.
We compared the RAMPAGE peak caller 10 with and without second read filtering to the Paraclu results. Because the RAMPAGE filter did not improve performance CapFilter (Supplementary Fig. 3b ), we did not include it in our main analysis.
Accuracy assessment. In order to estimate the accuracy of each method, we looked at the number of peaks that overlapped known TSSs based on the UCSC annotation (see "Corroborative data"). True positive (TP) peaks were defined as those that overlapped at least one annotated TSS, and false positive (FP) peaks as those that did not overlap any TSSs. Intergenic peaks did not overlap any genes according to the UCSC annotation. False negative (FN) peaks were defined as all annotated TSSs that (1) were within any gene expressed with TPM > 1
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(quantified using RSEM 66 (v.1.2.7) from 5′ RNA-seq data), (2) were overlapped by at least one DNase-seq peak (see "Corroborative data"), and (3) did not overlap any of the peaks called by ParaClu. We calculated the ROC curve for each method based on the peak scores output by Paraclu. We calculated sensitivity, precision, and F 1 score according to these formulas.
Sensitivity Precision Sensitivity Precision
In all cases, a 100-bp tolerance was considered an overlap, implemented using bedtools 'window' . For mouse-derived data, we modified the expression estimation pipeline, so that instead of using RSEM with its standard settings to quantify expression when defining false negatives, we first mapped the reads to the mm10 UCSC transcriptome using STAR and then applied RSEM to the resulting BAM file. In order to produce a BAM file that RSEM could use, we ran STAR with the following options: --quantMode TranscriptomeSAM, --alignIntronMax 1, --alignIntronMin 2, --scoreDelOpen -10000, and --scoreInsOpen -10000.
Corroborative data. H3K4me3 peaks were originally generated from ChIPSeq as part of the ENCODE Consortium 28 . We downloaded peaks from http:// hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHistone/ wgEncodeBroadHistoneK562H3k4me3StdPk.broadPeak.gz.
The associated GEO accession number is GSM733680. We obtained BAM files for K-562 DNase-1 hypersensitivity peaks (DNase-seq) from the SRA database (SRR231254 and SRR231189), called peaks with Macs2 (ref. 67 ) with the --nomodel option and default settings, and selected only peaks found in both replicates, by computing the intersection of the two replicates using bedtools 55 'intersect' . For the other DNase-seq datasets, we downloaded bed files containing peaks from the ENCODE portal 68 (ENCFF408UYX for MCF-7; ENCFF630GRU for mouse brain).
TSS annotations. Annotated TSSs were downloaded from the UCSC Coverage of peaks in brain-related samples. We sampled 13 million aligned reads from each brain-related dataset and called peaks with Paraclu and applied CapFilter as above. We combined the resulting peaks from all the samples into one file and merged with bedtools 55 . This ensures that slight differences in peak calls between samples (due to inherent randomness in the data) do not affect downstream analysis. We removed all peaks that did not overlap at least one annotated TSS within a tolerance of 100 bp. We used the bedtools coverage command to find the number of reads covering each peak, resulting in a matrix with one column for each sample and one row for each (merged) peak. We also used bedtools to annotate each peak to include the name of the gene in which it was located.
Coverage of peaks in FANTOM5 data. We downloaded FANTOM5 27 BAM files from http://fantom.gsc.riken.jp/5. In total we downloaded 12 samples: iPS day 18 of differentiation to neurons 69 , adult frontal cortex, adult and fetal occipital cortex, adult and fetal parietal cortex, and adult and fetal temporal cortex (Supplementary Table 10 ).
We processed the iPS and adult frontal cortex data through the same pipeline as our brain-related data, to generate a matrix with one column for each sample and one row for each (merged) peak. We used a similar pipeline for the remaining six samples, except instead of sampling 20 million reads, we sampled 6 million reads for the parietal cortex sample and 10 million reads for the remaining four samples because there were fewer reads for these samples. In addition, we were unable to apply CapFilter to the FANTOM5 reads because they were already trimmed.
Differential TSS usage.
To control for differences in overall gene expression, we computed the relative usage for each TSS i in gene j as
where r ij is the number of reads within TSS peak i in gene j, and k j is the number of TSSs in gene j. To identify differential usage, we considered all gene/sample pairs with > 100 reads, and compared the relative usage (rounded to the nearest integer) for the set of TSSs in a given gene between each pair of samples using Fisher's exact test implemented using the R function fisher.test in the stats package with default parameters, including alternative = 'two.sided' . More specifically, the test was performed on the 2 by k j table with one row per sample and one column per TSS, where the table entries are taken to be the corresponding R ij values (we use R ij values instead of raw counts to help correct for the number of reads per gene, which results in a more conservative test statistic). We then took the minimum P value across all comparisons, Bonferroni-corrected for the multiple comparisons per gene, reported as the P value for differential usage across the samples within a gene. Note that we compared only genes with at least 100 reads mapped to them in the samples of interest. We corrected Fisher P values for multiple hypothesis testing using the BenjaminiHochberg FDR correction, implemented using the R function p.adjust.
Testing upstream versus downstream bias in TSS usage. To test for upstream versus downstream bias in TSS usage between different brain samples, we used the peak by sample matrix generated above. For each gene and each sample, we calculated an average normalized peak score. More formally, for a given gene, if that gene had k peaks 1, 2, … , k (ordered from most to least upstream) and had n ij reads covering the jth peak in the ith gene, the score for that gene was equal to
The larger this score, the more that downstream peaks are used. We used a Wilcoxon signed-rank test (one-sided) to compare the average normalized peak scores for genes between samples. We corrected for multiple testing with Bonferroni correction (a total of 20 tests were made, 12 from our brain-related data, 8 from the FANTOM5 data).
Expression analysis.
To compare estimated gene expression values between samples ( Supplementary Fig. 10 ), we extracted TPM values from the RSEM results for each 5′ method, as well as from standard RNA-seq. We log-normalized these data before calculating the Pearson correlation coefficient, r.
The coloring in each comparison is based on a normalized density. For each pair of samples, we calculated this by removing all genes with TPM = 0 in either sample, and using a 2D Gaussian kernel-based density estimate, using the kde2d function in the R MASS package 70 . The density values were normalized to be between 0 and 1, to allow for a shared scale; this enabled us to see the relative density around each gene.
Statistics.
To compare TSS usage for a given gene between different conditions, we used Fisher's exact test (see "Differential TSS usage" for more details). For this test n = 2 (one sample for each condition). In order to test for differences in the number of TSSs used and 5′ biases between conditions, we used a one-sided Wilcoxon signed-rank test (see "Testing upstream versus downstream bias in TSS usage" for more details), with 95% confidence intervals estimated using a Gaussian approximation. Again, this test uses n = 2 (one sample for each condition). Multiple hypothesis testing was performed for all statistical tests using either Bonferroni or Benjamini-Hochberg FDR correction. All other statistics included in the paper are descriptive in nature. 
Reporting
Data exclusions
Describe any data exclusions.
No data was specifically excluded, but filtering was performed as described in the Methods section using Paraclu peak calling and CapFilter to exclude peaks not likely to be derived from true 5' ends.
Replication
Describe whether the experimental findings were reliably reproduced.
Replicate libraries were constructed for CAGE, RAMPAGE, and STRT with K-562 for method comparison --reproducibility was acceptable, see Supplementary Figures 9 and 10. Replicates were not done for the brain-related samples due to limited material, but our key findings were corroborated by analysis of published FANTOM5 data. All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For method comparison, we used the same commercial source for K-562 RNA and document the lot numbers used in Supplementary Table 1 . For the brain-related samples, all libraries were prepared and sequenced in the same batch. Samples were not randomized for the experiments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not relevant to our study. We used computational analysis methods that were intended to be unbiased in their evaluation of methods. We did not use any animals. There were no human participants to randomize --only commercially available samples.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Custom code was written in R (version 3.3) and Python (version 2.7) for specific functions as described in the Methods section. This custom code is available on Github at https://github.com/seanken/FivePrime. We also used Capfilter (a modified version is included on our Github), the Rampage peak calling pipeline, the Paraclu peak calling pipeline, and the Strand Invasion filter (see the associated publications and lab websites for code). In addition, we used STAR (version 2. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
